UPB – upstream bio, inc. (US:NASDAQ)
Stock Stats
News
Upstream Bio to Participate in the Piper Sandler 36th Annual Healthcare Conference
Upstream Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Upstream Bio, Inc. (NASDAQ: UPB) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $75.00 price target on the stock.
Upstream Bio, Inc. (NASDAQ: UPB) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $38.00 price target on the stock.
Upstream Bio, Inc. (NASDAQ: UPB) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
Form SEC STAFF LETTER Upstream Bio, Inc.
Form SEC STAFF LETTER Upstream Bio, Inc.
Form SC 13G Upstream Bio, Inc. Filed by: FMR LLC
Form 10-Q Upstream Bio, Inc. For: Sep 30
Form 8-K Upstream Bio, Inc. For: Nov 07
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.